BACKGROUND: This study was conducted to assess the efficacy and incidence of side effects of a regimen of repeated doses of 400 microg sublingual @entity396 for termination of pregnancy of <7 weeks gestation. METHOD: Fifty @entity1 were given 400 microg sublingual @entity396 every 3 h for three doses. Two additional doses were given if necessary. RESULTS: Forty-three @entity1 (86%) had a @entity5852 . Two @entity1 (4%) had @entity6003 and 5 (10%) had an ongoing pregnancy. The median interval between the first dose of @entity396 and the passage of tissue mass was 14.1 h (3.25-561.6 h). The median duration of @entity3556 was 20 days (8-85 days). Side effects were mild and there was no significant drop in hemoglobin level. CONCLUSIONS: Our preliminary results on sublingual @entity396 show that it is a promising method for medical termination of pregnancy of <7 weeks. It may be used as an alternative for @entity1 who do not want surgical evacuation and who live in an area where @entity3927 is not available.

Pilot study on the use of sublingual XXXX in termination of pregnancy up to 7 weeks gestation.

@entity1 :: ('9606', 'Species') :: ['women'] @entity6003 :: ('MESH:D000027', 'Disease') :: ['incomplete abortion'] @entity3556 :: ('MESH:D014592', 'Disease') :: ['vaginal bleeding'] @entity5852 :: ('MESH:D000031', 'Disease') :: ['complete abortion'] @entity396 :: ('MESH:D016595', 'Chemical') :: ['misoprostol'] @entity3927 :: ('MESH:D015735', 'Chemical') :: ['mifepristone']
@entity396 :: (MESH:D016595,Chemical) :: ['misoprostol']
